Background: Liver adenomatosis (LA) is a rare benign parenchymal liver disease with unknown aetiology. In recent reports, LA has been associated with hepatic steatosis, with potential implications for the management of this disease. The aim of this study was to determine prognosis and optimal management of patients with LA.
Methods: Clinical presentation, diagnostic studies and management of patients with LA were analysed in our centre. Furthermore, a Medline search of all published case reports and series of LA patients was performed.
Results: Ninety-four patients with LA have been reported in the literature. Fifty-two per cent of females had a history of oral contraceptive use. Eighteen per cent of patients had steatosis in nontumoral tissue. In our own series, five of six patients had histologically confirmed steatosis. Forty-three per cent of patients presented with acute pain, of whom 46% had a haemorrhagical complication, in contrast to 2% of nonsymptomatic patients. Tumours <5 cm tended to increase in size during follow-up and only in four patients tumour regression was observed.
Conclusion: Liver adenomatosis is a progressive, benign parenchymal disease mainly occurring in females. There is a potential link with hepatic steatosis with implications for the management of patients with LA. Noninvasive diagnosis is difficult because of the variety of tumoral and nontumoral components. Management should primarily be conservative.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/j.1478-3231.2008.01669.x | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Genomic and Transcriptomic Profile of HNF1A-Mutated Liver Adenomas Highlights Molecular Signature and Potential Therapeutic Implications.
Int J Mol Sci
September 2024
Immunogenetics and Transplant Biology Service, Azienda Ospedaliera-Universitaria Città della Salute e della Scienza, 10126 Turin, Italy.
Article Synopsis
- - Hepatocellular adenomas (HAs) are liver tumors linked to genetic mutations, with this study focusing on a 17-year-old with multiple HAs and a specific pathogenic mutation known to have a dominant negative effect.
- - The study identified additional somatic variants in some HAs and revealed significant transcriptomic changes, including alterations in various metabolic pathways, angiogenesis, and immune response.
- - Findings provide a detailed molecular profile of HAs associated with the identified mutation, paving the way for possible non-surgical treatment strategies by pinpointing new therapeutic targets.
Androgen-Induced, β-Catenin-Activated Hepatocellular Adenomatosis with Spontaneous External Rupture.
Diagnostics (Basel)
July 2024
Department of Pathology, NYU Langone Medical Center, New York University Grossman School of Medicine, 550 1st Avenue, New York, NY 10016, USA.
Article Synopsis
- Androgens are linked to causing liver tumors, both benign and malignant, such as hepatocellular adenoma and carcinoma, but the exact mechanisms are still unknown.
- A case study of a 24-year-old male who developed an androgen-induced hepatocellular adenoma revealed symptoms like severe abdominal pain and a history of testosterone use, leading to significant complications.
- The diagnosis involved imaging and biopsy, which confirmed atypical liver cells and highlighted the importance of considering androgen-induced liver tumors when diagnosing acute abdominal issues.
Liver Transplantation for Adenomatosis: A Single-Center Experience.
Transplant Proc
June 2024
Liver and Abdominal Organs Transplantation Division, Department of Gastroenterology, Hospital das Clínicas da Faculdade de Medicina de São Paulo (HC-FMUSP), São Paulo, Brazil; Laboratory of Medical Investigation 37 (LIM-37), Faculdade de Medicina da Universidade de São Paulo (FMUSP), Sao Paulo, Brazil.
Background: Liver adenomatosis is characterized by multiple adenomas diffusely distributed throughout the liver parenchyma. Studies addressing liver transplantation for those cases are scarce, and the criteria used to indicate transplantation are still debatable.
Objective: To report a single-center experience of liver transplantation for diffuse adenomatosis.
Paediatric hepatocellular adenomas: Lessons from a systematic review of relevant literature.
JHEP Rep
June 2024
Centre de recherche des Cordeliers, Sorbonne Université, Inserm, Université Paris Cité, team « Functional Genomics of Solid Tumors », Equipe labellisée Ligue Nationale Contre le Cancer, Labex OncoImmunology, F-75006 Paris, France.
Article Synopsis
- Hepatocellular adenomas (HCAs) are uncommon, benign liver tumors that affect both children and adults differently, necessitating a specific analysis of pediatric cases.
- A comprehensive study involving 316 children revealed that HCAs predominantly occur in girls around the age of 11.5, with a high prevalence linked to predisposing conditions such as glycogen storage disease, portosystemic shunts, and MODY3.
- Notably, complications like bleeding and tumor transformation were common, with management strategies varying based on the underlying diseases and tumor characteristics, including potential surgical interventions like resections or liver transplants.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!